Table 2. EBV antibodies in SLE patients and healthy controls (%).

	EBNA-1			EBV-VCA			EBV-EA/D
	IgG	IgA	IgM	IgG	IgA	IgM	IgG	IgA	IgM
SLE patients (n = 45)	82	0	0	100	18	16	62	58	67
Healthy controls (n = 40)	75	0	2.5	82.5	5	5	18	13	23
p-values for comparison	NS	NS	NS	NS	0.003	0.0007	0.0001	~0	0.0001

EBV—Epstein-Barr virus, SLE—systemic lupus erythematosus, EBNA-1 –EBV nuclear antigen 1, EBV-VCA—EBV viral capsid antigen, EBV-EA/D—EBV early antigen diffuse, NS—not significant.